MarginsXMarginsX
Home › Markets › Health Care › MIST

Milestone Pharmaceuticals Inc. Common Shares (MIST)

MIST trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$0.3650
-29.81% on the day
Market cap
$45.4M
Nano cap
Revenue
Foreign filer: no machine-readable annual figure in SEC data
Net income
Foreign filer: no machine-readable annual figure in SEC data

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.

Profile

FieldValue
TickerMIST on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryCanada
IPO year2019
SEC CIK0001408443
SEC industry codePharmaceutical Preparations
Incorporated inQC

Financials

Foreign filer: no machine-readable annual figure in SEC data.

Warning signs

Cash runway
22.6 months
$144.5M cash at September 30, 2026
Share count, 1 year
+46.2%
2025-11-12 to 2026-11-13 · +271.8% over 3 years
Going-concern doubt
No
10-Q filed November 13, 2026
Insider net buying, 12 months
-$860K
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.
"We believe there are currently no events or conditions that may cast substantial doubt on our ability to continue as a going concern for at least the next 12 months from the date of this filing."
10-Q 2026-11-13
Cash and burn$144.5M cash; operating cash flow -$19.2M a quarter.Report 2026-09-30
Shares outstanding124,498,693 (2026-11-13); 85,169,344 a year earlier; 33,483,111 three years earlier.Cover page 2026-11-13
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months1 S-3/F-3 shelf filings; 0 424B5 takedownsLatest 2026-05-13
Exchange deficiency notices, 12 months1 (8-K item 3.01)8-K 2026-10-28
AuditorPricewaterhouseCoopers LLP, Montreal, CanadaPCAOB Form AP 2026-04-09
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $860K on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$3.0M-$25.8M-$25.2M$144.5M$60.2MNeeds four quarters10-Q 2026-11-13
Q2 2026
2026-06-30
$559K-$28.6M-$22.7M$169.7M$59.2MNeeds four quarters10-Q 2026-08-12
Q1 2026
2026-03-31
$238K-$26.1M-$16.1M$71.3M$58.2MNeeds four quarters10-Q 2026-05-13
Q4 2025
2025-12-31
Not filed-$17.4M-$12.8M$73.0M$57.2MNeeds four quarters10-K 2026-03-20
Q3 2025
2025-09-30
$0-$11.9M-$9.7M$46.7M$56.2MNeeds four quarters10-Q 2026-11-13
Q2 2025
2025-06-30
$0-$13.0M-$12.6M$42.5M$55.2MNeeds four quarters10-Q 2026-08-12
Q1 2025
2025-03-31
$0-$20.8M-$14.0M$45.1M$54.3MNeeds four quarters10-Q 2026-05-13
Q4 2024
2024-12-31
Not filed-$12.4M-$6.8M$25.3M$53.4MNeeds four quarters10-K 2026-03-20

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-32026-05-13
Latest annual report10-K2026-03-20
Latest quarterly / interim10-Q2026-11-13
Latest current report
FORM 8-K
8-K2026-11-13
Latest proxyDEFA14A2026-04-30

Source: SEC EDGAR submissions feed, 423 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-31.8%
1 month-32.1%
3 months-51.4%
Year to date-74.3%
1 year-72.6%
From 52-week high-82.4%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
NMADNomad Power Solutions Inc.$2.80+19.15%$45.1M
RNXTRenovoRx Inc.$0.9549-8.18%$46.1M
TLPHTalphera Inc.$0.8609-4.98%$44.7M
HYFTMindWalk Holdings Corp.$0.9378-8.95%$44.6M
ONCYOncolytics Biotech Inc.$0.3399-8.14%$44.6M
ANVSAnnovis Bio Inc.$0.7500-19.02%$46.5M
ATNMActinium Pharmaceuticals Inc. (Delaware)$1.49-9.15%$46.8M
PLRXPliant Therapeutics Inc.$0.6932-0.55%$43.0M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier